Oxidative Stress and Endothelial Dysfunction in Cardiovascular Disease: Mitochondria-Targeted Therapeutics
Abstract
Functional impairment of endothelial activity (endothelial dysfunction) precedes the development of cardiovascular diseases (CVD). This condition is a result of a reduced bioavailability of nitric oxide (NO), a well known vasodilator, which is mainly due to increased NO degradation caused by its reaction with reactive oxygen species (ROS). Although there are several conditions that contribute independently to endothelial dysfunction, such as hyperglycemia, insulin resistance, hyperinsulinemia and dyslipidemia, increased oxidative stress seems to play a key role. In addition to their original pharmacological properties, drugs used clinically at present, including anti-hypertension reagents, angiotensin receptor blockers and anti-hyperlipidemic reagents such as statins, protect various organs via anti-oxidative stress mechanims. Moreover, some substances with antioxidant properties, such as vitamin C or vitamin E, have been used to erradicate the oxidative stress associated with CVD. The results of the clinical trials employing anti-oxidative stress reagents in patients with CVD are contradictory, which could be a result of inadequate study design or selected targets. This review considers the process of endothelial dysfunction and CVD from a mitochondrial perspective and evaluates strategies currently under development for the targeted delivery of antioxidants or NO to mitochondria. It endorses the idea that selectively targeting specific antioxidants and NO donors to mitochondria is an effective strategy for modulating mitochondrial respiration and ROS production and protecting mitochondria against oxidative stress. Keywords: Antioxidant, cardiovascular dysfunction, endothelium, mitochondria, nitric oxide, oxidative stress, reactive oxygen species, endothelial dysfunction, cardiovas-cular diseases (CVD), bioavailability, reactive oxygen species (ROS), hyperglycemia, insu-lin resistance, hyperinsulinemia, dyslipidemia, angiotensin, vitamin C, vitamin E, endothelium, mitochondria, electron transport chain (ETC), atherosclerosis, endothelium-dependent vasodilatation, NITROGEN SPECIES (RONS), oxidative, fragmentation, lipid car-diolipin, glutathione peroxidases (GPx), metal-binding proteins, transferrin, lactoferrin, metal-lothionein, carotenoids, lipoic acid, tocopherols, N-acetyl cysteine (NAC), neuroprotective, Mitochondrial dysfunction, cell necrosis, neurodegenerative diseases, nitroglycerine, membrane depolarisation, cytochrome, synaptosomes, dyslipemia, obesity, antifibrinolitic, vasoconstrictor, proinflammatory, asymmetric dimethylargin-ine, hy-percholesterolemic, hydroxyocta-decaenoic acids (HODEs), hydroxyeicosatetraenoic acids (HETEs, The Probucol Quantitative Regression Study (PQRST), triphenylphosphonium (TPP), ubiquinol (MitoQ), S-Nitrosothiols (SNOs)
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Mitochondrial dysregulation is implicated in impaired arterial function in animal models of cardiovascular disease.
“Accumulating evidence implicates mitochondrial dysregulation in impaired arterial function both in animal models of cardiovascular disease (94, 161, 182)”
From Inorganic nitrite supplementation for healthy arterial aging (2014) · cites this paper as [161]
Cited by
Sorted by citations
Assessing mitochondrial dysfunction in cells
Brand, M. D., & Nicholls, D. G. (2011) · Biochemical Journal · doi:10.1042/bj20110162 · Cited by 2,436 · see citing works
Mitochondria and Reactive Oxygen Species: Physiology and Pathophysiology
Bolisetty, S., & Jaimes, E. A. (2013) · International Journal of Molecular Sciences · doi:10.3390/ijms14036306 · Cited by 274 · see citing works
“cellular processes, it is not surprising that damage to the mitochondria has been implicated in the pathogenesis of end-organ injury in a variety of diseases [4–23].”
BackgroundSchulz, E., Wenzel, P., Münzel, T. F., & Daiber, A. (2012) · Antioxidants and Redox Signaling · doi:10.1089/ars.2012.4609 · Cited by 253 · see citing works
“Moreover, numerous examples exist that therapy with mitochondria-targeted antioxidants improves endothelial dysfunction (108).”
Highly efficient conversion of superoxide to oxygen using hydrophilic carbon clusters
Samuel, E. L. G., Marcano, D. C., Berka, V., Bitner, B. R., Wu, G., Potter, A., Fabian, R. H., Pautler, R. G., Kent, T. A., Tsai, A.-L., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417047112 · Cited by 214 · see citing works
Marzetti, E., Csiszár, A., Dutta, D., Balagopal, G., Calvani, R., & Leeuwenburgh, C. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00936.2012 · Cited by 197 · see citing works
Mikhed, Y., Görlach, A., Knaus, U. G., & Daiber, A. (2015) · Redox Biology · doi:10.1016/j.redox.2015.05.008 · Cited by 181 · see citing works
“mitochondria-targeted compounds such as mitoQ) [90], activators of endogenous antioxidant pathways (e.”
BackgroundThe Role of Mitochondria in Cardiovascular Diseases
Poznyak, A. V., Ivanova, E. A., Sobenin, I. A., Yet, S., & Orekhov, A. N. (2020) · Biology · doi:10.3390/biology9060137 · Cited by 149 · see citing works
“Mitochondria participate in all these processes, leading to their identification as an attractive possible point of therapeutic intervention [3].”
BackgroundRole of Lipotoxicity in Endothelial Dysfunction
Kim, J., Montagnani, M., Chandrasekran, S., & Quon, M. J. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.012 · Cited by 146 · see citing works
Guo, C., Wang, J., Li, J., Ma, R., Liu, X., Gao, L., Cao, L., Duan, J., Zhou, X., Li, Y., et al. (2017) · Environmental Pollution · doi:10.1016/j.envpol.2017.10.060 · Cited by 145 · see citing works
“Endothelial dysfunction precedes cardiovascular disease (Rocha et al., 2010).”
Cydonia oblonga M., A Medicinal Plant Rich in Phytonutrients for Pharmaceuticals
Ashraf, M. U., Muhammad, G., Hussain, M. A., & Bukhari, S. N. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00163 · Cited by 130 · see citing works
Goldstein, B. I., Baune, B. T., Bond, D. J., Chen, P., Eyler, L. T., Fagiolini, A. M., Gomes, F. A., Hájek, T., Hatch, J. K., McElroy, S. L., et al. (2020) · Bipolar Disorders · doi:10.1111/bdi.12921 · Cited by 112 · see citing works
Age related changes of the extracellular matrix and stem cell maintenance
Kurtz, A., & Oh, S.-J. (2012) · Preventive Medicine · doi:10.1016/j.ypmed.2012.01.003 · Cited by 112 · see citing works
SIRT3 Mediates the Antioxidant Effect of Hydrogen Sulfide in Endothelial Cells
Xie, L., Feng, H., Li, S., Meng, G., Liu, S., Tang, X., Ma, Y., Han, Y., Xiao, Y., Gu, Y., et al. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6331 · Cited by 106 · see citing works
“Oxidative stress can be broadly defined as an imbalance of ROS production over antioxidant defenses.”
InfluentialLuan, Y., Luan, Y., Yuan, R., Feng, Q., Chen, X., & Yang, Y. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4578809 · Cited by 105 · see citing works
“Meanwhile, a failing heart is accompanied by defected oxidative phosphorylation (OXPHOS) and decreased ATP levels, contributing to defective cardiac performance [10].”
BackgroundMitochondrial membrane potential is regulated by vimentin intermediate filaments
Chernoivanenko, I. S., Matveeva, E. A., Gelfand, V. I., Goldman, R. D., & Minin, A. А. (2014) · The FASEB Journal · doi:10.1096/fj.14-259903 · Cited by 102 · see citing works
Role of mitochondrial reactive oxygen species in age-related inflammatory activation of endothelium
Zinovkin, R. A., Romaschenko, V. P., Galkin, I. I., Zakharova, V., Pletjushkina, O. Y., Chernyak, B. V., & Popova, E. N. (2014) · Aging · doi:10.18632/aging.100685 · Cited by 89 · see citing works
Ishii, S., Miyao, M., Mizuno, Y., Tanaka-Ishikawa, M., Akishita, M., & Ouchi, Y. (2013) · Osteoporosis International · doi:10.1007/s00198-013-2571-7 · Cited by 77 · see citing works
“However, there is also strong evidence linking hyperuricemia with increased risk of cardiovascular disease [17, 18] in which oxidative stress plays an important pathophysiological role [19, 20].”
BackgroundKlein, S. G., Cambier, S., Hennen, J., Legay, S., Serchi, T., Nelissen, I., Chary, A., Moschini, E., Krein, A., Blömeke, B., et al. (2017) · Particle and Fibre Toxicology · doi:10.1186/s12989-017-0186-4 · Cited by 75 · see citing works
“Endothelial dysfunction plays a central role in the pathogenesis of several cardiovascular diseases [16] and it precedes, in general, cardiovascular disease [17].”
BackgroundInorganic nitrite supplementation for healthy arterial aging
Sindler, A. L., DeVan, A. E., Fleenor, B. S., & Seals, D. R. (2014) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01100.2013 · Cited by 68 · see citing works
Daiber, A., Oelze, M. W., Steven, S., Kröller‐Schön, S., & Münzel, T. F. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.001 · Cited by 62 · see citing works
“mitochondria-targeted compounds such as mitoQ) [18], activators of endogenous antioxidant pathways (e.”
BackgroundLiu, L., Yan, L., Chen, Y., Zeng, G.-H., Zhou, Y., Chen, H., Peng, W., He, M. L., & Huang, Q. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.010 · Cited by 60 · see citing works
Piroddi, M., Pilolli, F., Aritomi, M., et al. (2012) · American Journal of Nephrology · doi:10.1159/000338807 · Cited by 53 · see citing works
Huang, M., Yang, Y., Liu, X., Qin, Z., & Li, J. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14592 · Cited by 52 · see citing works
Cross-talk between SIRT1 and p66Shc in vascular diseases
Chen, H., Wan, Y.-Z., & Liu, D. (2013) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2013.01.001 · Cited by 49 · see citing works
Nesuashvili, L., Hadley, S. H., Bahia, P. K., & Taylor‐Clark, T. E. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.084319 · Cited by 50 · see citing works
“Mitochondrial dysfunction and subsequent ROS production occurs in diseases such as type II diabetes, irritable bowel syndrome, and cardiovascular disease (Hall and Wiley, 1998; Rocha et al., 2010; Chowdhury et al., 2013).”
BackgroundPeng, Y., Lin, Y., Chen, Y., et al. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23435 · Cited by 48 · see citing works
“In fact, mitochondria are the major sources of ROS production [Rocha et al., 2010].”
BackgroundPan, Y., Chen, D., Lu, Q., Liu, L., Li, X., & Li, Z. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6904 · Cited by 40 · see citing works
Mao, C.-Y., Lu, H., Kong, N., Li, J., Liu, M., Yang, C., & Yang, P. (2014) · International Journal of Medical Sciences · doi:10.7150/ijms.9153 · Cited by 38 · see citing works
“Oxidative stress is characterized by excessive reactive oxygen species (ROS) production and reduced cellular antioxidant activity, leading to membrane lipid peroxidation and mitochondrial dysfunction [6].”
BackgroundChoi, Y. J., Kim, D. H., Kim, S. J., Kim, J., Jeong, S.-I., Chung, C. H., Yu, K.-Y., & Kim, S. Y. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.05.012 · Cited by 38 · see citing works
Yang, L., Qu, M., Wang, Y., Duan, H., Chen, P., Wang, Y., Shi, W., Danielson, P., & Zhou, Q. (2013) · Molecular Pharmacology · doi:10.1124/mol.112.081059 · Cited by 38 · see citing works
“Human corneal fibroblasts were loaded with DCHFDA and PFBSF to detect the accumulation of intracellular ROS and H2O2, respectively.”
BackgroundInfluentialZhou, Q., Duan, H., Wang, Y., Qu, M., Yang, L., & Xie, L. (2012) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0429 · Cited by 36 · see citing works
Majima, H. J., Indo, H. P., Suenaga, S., Matsui, H., Yen, H., & Ozawa, T. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796957490 · Cited by 34 · see citing works
Cheng, D., Liu, X., Gao, Y., et al. (2023) · Antioxidants and Redox Signaling · doi:10.1089/ars.2022.0215 · Cited by 32 · see citing works
“C ardiovascular disease (CVD) is the most common disease among elderly people > 50 years old.”
InfluentialWang, X., Wang, Z., Liu, D., Jiang, H., Cai, C., Li, G., & Yu, G. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.839640 · Cited by 26 · see citing works
Nitric Oxide and Protection against Cardiac Ischemia
Xia, Z., & Vanhoutte, P. M. (2011) · Current Pharmaceutical Design · doi:10.2174/138161211796391047 · Cited by 24 · see citing works
Sulfuretin protects hepatic cells through regulation of ROS levels and autophagic flux
Lu, Y., Xiao, Y., Li, Y., Li, J. X., Nan, F., & Li, J. (2018) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0193-5 · Cited by 22 · see citing works
Sen, U., Pushpakumar, S. B., Amin, M., & Tyagi, S. C. (2014) · Nitric Oxide · doi:10.1016/j.niox.2014.06.006 · Cited by 22 · see citing works
“Since eNOS derived NO is the primary vasorelaxation factor under physiological conditions, the cells are deprived of NO following endothelial injury [64], leading to impaired endothelial function [65; 66].”
BackgroundAlterations to vascular endothelium in the optic nerve head in patients with vascular comorbidities
Kang, M. H., Balaratnasingam, C., Yu, P. K., Morgan, W. H., McAllister, I. L., Cringle, S. J., & Yu, D. (2013) · Experimental Eye Research · doi:10.1016/j.exer.2013.03.005 · Cited by 19 · see citing works
Melo, D., de Oliveira, N. M., Lopes, L. T., Machado, J. P., & Oliveira, M. B. P. P. (2022) · Plants · doi:10.3390/plants11192638 · Cited by 18 · see citing works
Mitochondria-Targeted Vitamin E Protects Skin from UVB-Irradiation
Kim, W.-S., Kim, I., Kim, W.-K., Choi, J., Kim, D. Y., Moon, S.-G., Min, H.-K., Song, M.-K., & Sung, J.-H. (2016) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2015.131 · Cited by 17 · see citing works
“…within mitochondria and to decrease mitochondrial oxidative damage to inhibit a range of human disorders, including neurodegenerative diseases, ischemia-reperfusion injury, and aging-associated dysfunctions (Mao et al., 2010; Rocha et al., 2010; Mao et al., 2011; Ajith and Jayakumar, 2014).”
BackgroundEl‐Shiekh, R. A., Saber, F. R., & Abdel-Sattar, E. A. (2020) · Journal of Chromatography B · doi:10.1016/j.jchromb.2020.122334 · Cited by 17 · see citing works
Rota, F., Ferrari, L., Hoxha, M., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77097-9 · Cited by 17 · see citing works
Blanc, S. L., Villarroel, P., Candia, V., Gavilán, N., Néstor Soto, I., Pérez‐Bravo, F., & Arredondo, M. (2012) · BioMetals · doi:10.1007/s10534-012-9540-z · Cited by 16 · see citing works
Arce, P. M., Goldschmidt, R., Khdour, O. M., Madathil, M. M., Jaruvangsanti, J., Dey, S., Fash, D. M., Armstrong, J. S., & Hecht, S. M. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.07.005 · Cited by 16 · see citing works
The Mitoscriptome in Aging and Disease.
Raju, R. P., Jian, B., Hubbard, W. J., & Chaudry, I. H. (2011) · Europe PMC (PubMed Central) · Cited by 17 · see citing works
Protective effects of green tea on antioxidative biomarkers in chemical laboratory workers
Tavakol, H. S., Ranjbar, A., Azam, S., et al. (2013) · Toxicology and Industrial Health · doi:10.1177/0748233713484659 · Cited by 16 · see citing works
“Pathological effects have been reported for chronic ROS in several diseases such as chronic renal failure (Rocha et al., 2010), atherosclerosis (Leitinger, 2003), organophosphorus insecticides effects (Ranjbar et al., 2002), and operating room (Ranjbar et al., 2007).”
BackgroundMonocyte gene expression and coronary artery disease
Maiwald, S., Zwetsloot, P.-P. M., Sivapalaratnam, S., & Dallinga‐Thie, G. M. (2013) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e32836236f9 · Cited by 16 · see citing works
“ROS interferes with nitric oxide causing endothelial dysfunction [52].”
BackgroundPotential of Cydonia oblonga leaves in cardiovascular disease.
Vaez, H., Hamidi, S., & Arami, S. (2014) · Hypothesis · doi:10.5779/hypothesis.v12i1.356 · Cited by 15 · see citing works
Exercise improves high fat diet-impaired vascular function
Fang, J., & Tang, M. K. (2017) · Biomedical Reports · doi:10.3892/br.2017.972 · Cited by 13 · see citing works
“ROS are produced during mitochondrial respiration, as well as from outside the mitochondria, via free fatty acid β -oxidation, nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, xanthine oxidase, lipoxygenase and cyclooxygenases (18,19).”
Lactylation in Cardiovascular Diseases: Current Progress and Perspectives
Wang, Z., Yu, Q., Wang, C., Wang, S., Wang, P., Zhang, L., & Han, S. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.125.043801 · Cited by 13 · see citing works
Pratte, P., Cosandey, S., & Ginglinger, C. G. (2017) · Journal of Aerosol Science · doi:10.1016/j.jaerosci.2017.12.011 · Cited by 12 · see citing works
Mattingly, K. A., & Klinge, C. M. (2011) · Archives of Toxicology · doi:10.1007/s00204-011-0778-y · Cited by 10 · see citing works
“Endothelial dysfunction precedes cardiovascular disease and is accompanied by mitochondrial dysfunction (Rocha et al. 2010).”
BackgroundChen, W., Liu, Y., Xue, G., et al. (2015) · Inflammation Research · doi:10.1007/s00011-015-0890-1 · Cited by 10 · see citing works
“It is characterized by superabundant ROS production and reduced antioxidant activity of cells, resulting in membrane lipid peroxidation, mitochondrial dysfunction and even initiating apoptosis [15].”
Zhang, Y., Li, W., Zhang, X.-Y., et al. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.01.071 · Cited by 10 · see citing works
Valerio, V., Keceli, G., Moschetta, D., Porro, B., Ciccarelli, M., Massaiu, I., Songia, P., Maione, A. S., Alfieri, V., Myasoedova, V. A., et al. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0133 · Cited by 9 · see citing works
“Oxidative stress, stemming from an imbalance between reactive oxygen species (ROS) formation and scavenging, is one factor that chiefly accounts for this alteration (22, 32, 59).”
Latha, R., Shanthi, P., & Sachdanandam, P. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/cjpp-2012-0292 · Cited by 9 · see citing works
Cordeiro, E. R., Filetti, F. M., Simões, M. R., & Vassallo, D. V. (2019) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2019.114710 · Cited by 9 · see citing works
Huang, J., Zhao, L., Gong, C., et al. (2021) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2021/5386050 · Cited by 8 · see citing works
“Superabundant ROS production reduced antioxidant activity in cells, resulting in membrane lipid peroxidation, mitochondrial dysfunction, and apoptosis [26].”
BackgroundŠušnjara, P., Kolobarić, N., Matić, A., et al. (2022) · Frontiers in Bioscience-Landmark · doi:10.31083/j.fbl2712332 · Cited by 8 · see citing works
Xu, Q., Zhang, B., Li, X.-M., et al. (2012) · Acta Pharmacologica Sinica · doi:10.1038/aps.2011.191 · Cited by 8 · see citing works
MicroRNA-214 protects L6 skeletal myoblasts against hydrogen peroxide-induced apoptosis
Chen, W., Zhang, Y., Jia, Q.-Q., Ji, A., Shao, S., Zhang, L., Gong, M., Yin, Q., & Huang, X. (2020) · Free Radical Research · doi:10.1080/10715762.2020.1730828 · Cited by 8 · see citing works
“cells, leading to membrane lipid peroxidation, mitochondrial dysfunction and even apoptosis [29].”
BackgroundMitochondria dysfunction: A trigger for cardiovascular diseases in systemic lupus erythematosus
Wang, H., Tang, R., Pan, Q., Yin, Q., Feng, J., & Deng, L. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113722 · Cited by 7 · see citing works
Antimycin A increases bronchopulmonary C-fiber excitability via protein kinase C alpha
Bahia, P. K., Hadley, S. H., Barannikov, I., Sowells, I., Kim, S.-H., & Taylor‐Clark, T. E. (2020) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2020.103446 · Cited by 6 · see citing works
Lin, H., Cheng, P., Tu, Y.-C., et al. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab029 · Cited by 5 · see citing works
Mishra, D., Mohapatra, L., Bandyopadhyay, D., Parida, S. K., & Palei, N. N. (2025) · Journal of Biochemical and Molecular Toxicology · doi:10.1002/jbt.70522 · Cited by 3 · see citing works
“A possible therapy that relies on the use of miniature form anti-oxidants to be pharmaceutically viable is boosting antioxidant capacity, especially in the mitochondrial storage [128, 130].”
Cardiac Metabolism Imaging and Chemotherapy Cardiotoxicity
Croteau, É. (2014) · Journal of Clinical Toxicology · doi:10.4172/2161-0495.1000213 · Cited by 3 · see citing works
“As the mitochondria are the major intracellular source of ROS production, further investigation of strategies to protect the mitochondria from oxidative stress is required [69].”
BackgroundMagnetic Fields Trump Oxygen in Controlling the Death of Erythro-Leukemia Cells
Li, Y., & Héroux, P. (2019) · Applied Sciences · doi:10.3390/app9245318 · Cited by 3 · see citing works
Ethnopharmacological and toxicological review of Cydonia oblonga M.
Cvetkovska, K., & Bauer, B. (2018) · Macedonian Pharmaceutical Bulletin · doi:10.33320/maced.pharm.bull.2018.64.02.001 · Cited by 2 · see citing works
Fidan, V., Alp, H. H., Karaca, F., et al. (2012) · Journal of International Medical Research · doi:10.1177/147323001204000218 · Cited by 1 · see citing works
Serum Uric Acid and Biomarkers of Lumbar Spine Bone Mineral Density
Yang, Y., & Ishii, S. (2017) · Biomarkers in disease · doi:10.1007/978-94-007-7693-7_1 · Cited by 1 · see citing works
Reactive Oxygen Species and Atherosclerosis
Víctor, V. M. (2014) · Springer eBooks · doi:10.1007/978-3-642-30018-9_53 · Cited by 1 · see citing works
Self-citationTomić, J. (2013) · University Library - University of Saskatchewan (University of Saskatchewan)
Pratte, P., Schaller, J., & Maeder, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820490-0.00012-2
Wang, X., Wang, Z., Liu, D., Jiang, H., Cai, C., Li, G., & Yu, G. (2021) · Research Square · doi:10.21203/rs.3.rs-754308/v1
Serum Uric Acid and Biomarkers of Lumbar Spine Bone Mineral Density
Yang, Y., & Ishii, S. (2015) · Exposure and Health · doi:10.1007/978-94-007-7745-3_1-1
- Authors
- Rocha, M., Apostolova, N., Hernandez-Mijares, A., Herance, R., & M. Victor, V.
- Affiliations
- Hospital Universitario Doctor Peset (ES)
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2010-11-01
- Volume
- 17
- Issue
- 32
- Pages
- 3827-3841
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2078127184
- Cited by
- 75
- References
- 0
- Citations by year
- 2025: 2 · 2024: 1 · 2023: 1 · 2022: 4 · 2021: 5 · 2020: 6 · 2019: 3 · 2018: 2 · 2017: 8 · 2016: 2 · 2015: 5 · 2014: 10 · 2013: 10 · 2012: 10
- FWCI
- 5.63
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mitochondrial Function and Pathology
- Health Sciences › Medicine › Biochemistry › Antioxidant Activity and Oxidative Stress
- Keywords
- endothelial dysfunction, oxidative stress, cardiovascular disease, mitochondria-targeted antioxidants, nitric oxide bioavailability, reactive oxygen species, mitochondrial respiration, electron transport chain, glutathione peroxidase, metal-binding proteins, alpha-lipoic acid, tocopherols, N-acetylcysteine, mitochondrial dysfunction, atherosclerosis, endothelium-dependent vasodilatation
- MeSH terms
- Antioxidants, Cardiovascular Diseases, Humans, Mitochondria, Reactive Oxygen Species, Oxidative Stress, Reactive Nitrogen Species, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
